TMCnet News

Research and Markets: Global Dementia Associated With Alzheimer's Disease Pipeline Review Report 2014
[April 15, 2014]

Research and Markets: Global Dementia Associated With Alzheimer's Disease Pipeline Review Report 2014


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/5kd8th/dementia) has announced the addition of the "Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Dementia Associated With Alzheimer's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dementia Associated With Alzheimer's Disease and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new target and MOAs to produce first-in-class and best-in-class products.



Scope

  • The report provides a snapshot of the global therapeutic landscape of Dementia Associated With Alzheimer's Disease
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Dementia Associated With Alzheimer's Disease and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Dementia Associated With Alzheimer's Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Dementia Associated With Alzheimer's Disease pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Dementia Associated With Alzheimer's Disease - Companies Involved in Therapeutics Development


  • Kowa Company, Ltd.
  • MediPost Co., Ltd.
  • e-Therapeutics plc
  • Adamas Pharmaceuticals, Inc.
  • Chase Pharmaceuticals Corporation

Drug Profiles

  • (memantine hydrochloride ER + donepezil hydrochloride)
  • K-828-AB
  • Neurostem
  • TAK-070
  • ETX-6765
  • CPC (News - Alert)-001
  • erlotinib hydrochloride
  • gefitinib
  • AVCRI-104P3

For more information visit http://www.researchandmarkets.com/research/5kd8th/dementia


[ Back To TMCnet.com's Homepage ]